Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Preclinical Imaging (In-VIVO) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.0% during the forecast period.
This report presents the market size and development trends by detailing the Preclinical Imaging (In-VIVO) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Preclinical Imaging (In-VIVO) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Preclinical Imaging (In-VIVO) industry and will help you to build a panoramic view of the industrial development.
Preclinical Imaging (In-VIVO) Market, By Type:
Modality
Reagent
Others
Preclinical Imaging (In-VIVO) Market, By Application:
Oncology
Cardio and Vascular
Neurology
Others
Some of the leading players are as follows:
MILabs B.V.
PerkinElmer
Miltenyi Biotec
Bruker Corporation
Trifoil Imaging
LI-COR Biosciences
MR Solutions
Mediso
Aspect Imaging
MILabs BV
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Preclinical Imaging (In-VIVO) Market: Technology Type Analysis
-
4.1 Preclinical Imaging (In-VIVO) Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Preclinical Imaging (In-VIVO) Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Modality
4.3.2 Reagent
4.3.3 Others
5 Preclinical Imaging (In-VIVO) Market: Product Analysis
-
5.1 Preclinical Imaging (In-VIVO) Product Market Share Analysis, 2018 & 2026
-
5.2 Preclinical Imaging (In-VIVO) Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Preclinical Imaging (In-VIVO) Market: Application Analysis
-
6.1 Preclinical Imaging (In-VIVO) Application Market Share Analysis, 2018 & 2026
-
6.2 Preclinical Imaging (In-VIVO) Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oncology
6.3.2 Cardio and Vascular
6.3.3 Neurology
6.3.4 Others
7 Preclinical Imaging (In-VIVO) Market: Regional Analysis
-
7.1 Preclinical Imaging (In-VIVO) Regional Market Share Analysis, 2018 & 2026
-
7.2 Preclinical Imaging (In-VIVO) Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 MILabs B.V.
9.1.1 MILabs B.V. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 PerkinElmer
9.2.1 PerkinElmer Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Miltenyi Biotec
9.3.1 Miltenyi Biotec Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Bruker Corporation
9.4.1 Bruker Corporation Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Trifoil Imaging
9.5.1 Trifoil Imaging Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 LI-COR Biosciences
9.6.1 LI-COR Biosciences Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 MR Solutions
9.7.1 MR Solutions Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Mediso
9.8.1 Mediso Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Aspect Imaging
9.9.1 Aspect Imaging Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 MILabs BV
9.10.1 MILabs BV Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 67 Figures and 138 Tables)
Figure Modality Preclinical Imaging (In-VIVO) market, 2015 - 2026 (USD Million)
Figure Reagent Preclinical Imaging (In-VIVO) market, 2015 - 2026 (USD Million)
Figure Others Preclinical Imaging (In-VIVO) market, 2015 - 2026 (USD Million)
Figure Oncology market, 2015 - 2026 (USD Million)
Figure Cardio and Vascular market, 2015 - 2026 (USD Million)
Figure Neurology market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Preclinical Imaging (In-VIVO) market, by country, 2015 - 2026 (USD Million)
-
Table North America Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table North America Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table North America Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Canada Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Canada Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Europe Preclinical Imaging (In-VIVO) market, by country, 2015 - 2026 (USD Million)
-
Table Europe Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Europe Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Europe Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Germany Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Germany Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table France Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table France Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Italy Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Italy Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Spain Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Spain Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical Imaging (In-VIVO) market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table China Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table China Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Japan Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Japan Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table India Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table India Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical Imaging (In-VIVO) market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table MEA Preclinical Imaging (In-VIVO) market, by country, 2015 - 2026 (USD Million)
-
Table MEA Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table MEA Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table MEA Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Preclinical Imaging (In-VIVO) market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Preclinical Imaging (In-VIVO) market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Preclinical Imaging (In-VIVO) market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table MILabs B.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PerkinElmer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Miltenyi Biotec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bruker Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Trifoil Imaging Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table LI-COR Biosciences Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MR Solutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mediso Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aspect Imaging Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MILabs BV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
